Fundraising Fox
🦊/People
Sign in

Don Frail

Investor

Senior Advisor at Frazier Life Sciences · Senior Advisor at Frazier Healthcare Partners

United States

Find your path to Don

483 people in our graph share verified history with Don — schools, employers, funds. One of them is your warm intro.

Johannes FruehaufunlockedDon: together at Pandion Therapeutics (2019–2020)
×3Don: together at AstraZeneca
×3Don: together at Stony Brook University
Don: together at Washington University School of Medicine in St. Louis

About

Don Frail is founder and CEO of Alceptor Therapeutics and has held senior leadership positions in drug discovery and clinical development across multiple therapeutic areas. He has built and managed R&D organizations ranging from 25 to 200 employees, with experience advancing more than 25 compounds into clinical development across modalities including small molecules, monoclonal antibodies, gene therapy, and CRISPR. Since 2015, Frail has participated in more than 25 business development transactions, including acquisitions, licensing agreements, and partnership structures.

Experience

  1. Alceptor TherapeuticsFounder, CEO, Board Membercurrent2020 — presentSouthern California
  2. Frazier Healthcare PartnersSenior Advisorcurrent2020 — presentSouthern California
  3. Iolyx TherapeuticsBoard Membercurrent2021 — presentSan Francisco Bay Area
  4. Ventyx BiosciencesScientific Advisory Board2024 — 2026
  5. Escient PharmaceuticalsScientific Advisory Board2022 — 2024San Diego, CA
  6. Pandion TherapeuticsBoard Member2019 — 2021Cambridge, Massachusetts, United States
  7. AllerganSenior Vice President, Research, External Science & Innovation, Non-Clinical/Translational Sciences2014 — 2020Irvine, CA
  8. AstraZenecaVice President, Science, New Opportunities iMed/Emerging Innovations Unit2011 — 2014Greater Boston Area
  9. PfizerVice President, Pfizer Global Research and Development2007 — 2011St Louis, Missouri, United States
  10. PfizerVice President, Biology, Saint Louis Discovery2003 — 2007St Louis, Missouri, United States
  11. Pharmacia CorporationVice President, CNS Discovery2001 — 2003Kalamazoo, Michigan, United States
  12. WyethDirector, Women's Health1994 — 2001Radnor Township, Pennsylvania, United States

Skills & more

Drug DiscoveryDrug DevelopmentClinical DevelopmentTherapeutic AreasClinical TrialsClinical ResearchCROEndocrinologyMedicineBiomarker DiscoveryPharmaceutical IndustryNeuroscience
+8 morePharmacologyOncologyScienceBiotechnologyLaboratoryR&DBiochemistryTranslational Medicine

From Don's professional profile.

Colleagues at Frazier Life Sciences

Adam Simpson
Venture Partner at Frazier Life Sciences
Aditya Kohli
Partner at Frazier Life Sciences
Alan Frazier
Chairman Emeritus at Frazier Life Sciences
Albert Cha
Managing Partner at Frazier Life Sciences
Ali Jackson
Vice President and Counsel, Public Funds at Frazier Life Sciences
Amanda Wilson
Senior Tax Manager at Frazier Life Sciences
Angel Martin
Senior Associate at Frazier Life Sciences
Angie You
Senior Advisor at Frazier Life Sciences

Frequently asked questions

Who is Don Frail?
Don Frail is founder and CEO of Alceptor Therapeutics and has held senior leadership positions in drug discovery and clinical development across multiple therapeutic areas. He has built and managed R&D organizations ranging from 25 to 200 employees, with experience advancing more than 25 compounds into clinical development across modalities including small molecules, monoclonal antibodies, gene therapy, and CRISPR. Since 2015, Frail has participated in more than 25 business development transactions, including acquisitions, licensing agreements, and partnership structures.
Where does Don Frail work?
Don Frail is Senior Advisor at Frazier Life Sciences.
Where did Don Frail go to school?
Don Frail studied at Washington University School of Medicine in St. Louis (Post Doctoral Fellow); McGill University (Doctor of Philosophy (Ph.D.)); Stony Brook University (Bachelor of Science - BS, Biology and Mathematics).

Same school

Shared employers